Biostar Pharmaceuticals (BSPM) Swings to Q2 Profit

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q2 EPS of $0.11, versus ($0.06) reported last year. Revenue for the quarter came in at $19.2 million, versus $14.65 million reported last year.

For earnings history and earnings-related data on Biostar Pharmaceuticals (BSPM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• Vivos Therapeutics posts 35% revenue gain but widens net loss